CH5424802 is current under Phase I/II studies in patients with ALK-rearranged non-small cell lung cancer.

June 21, 2017

prudect name : CH5424802 is current under Phase I/II studies in patients with ALK-rearranged non-small cell lung cancer.
CH 5424802

Synonyms: CAS NO: 1256580-46-7Molecular Formula: C₃₀H₃₄N₄O₂Molecular Weight: 482.62Purity: 98%Solubility: In DMSOStorage: -20°C

CDK7 inhibitor References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18505803